RadioGel® is not FDA-approved for commercial use in the United States.

RadioGelUSA
Home
The Science of RadioGel®
Subscribe
PRnT™
Research Papers
IDE Submission
Press Releases
RadioGel® Cancer Blog
Meet The Team
Contact Us
Vivos Inc.
IsoPet®
RadioGelUSA
Home
The Science of RadioGel®
Subscribe
PRnT™
Research Papers
IDE Submission
Press Releases
RadioGel® Cancer Blog
Meet The Team
Contact Us
Vivos Inc.
IsoPet®
More
  • Home
  • The Science of RadioGel®
  • Subscribe
  • PRnT™
  • Research Papers
  • IDE Submission
  • Press Releases
  • RadioGel® Cancer Blog
  • Meet The Team
  • Contact Us
  • Vivos Inc.
  • IsoPet®
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out


Signed in as:

filler@godaddy.com

  • Home
  • The Science of RadioGel®
  • Subscribe
  • PRnT™
  • Research Papers
  • IDE Submission
  • Press Releases
  • RadioGel® Cancer Blog
  • Meet The Team
  • Contact Us
  • Vivos Inc.
  • IsoPet®

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

Vivos Inc.'s animal division treating cancer in animals

Vivos Inc. holds the patent for Precision Radionuclide Therapy™ (PRnT™) which is changing the way cancer is treated in animals. Currently we have been treating cats, dogs and horses in 8 regional clinics across the USA since 2018.

www.isopet.com

Copyright © 2025 RadioGel™ - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept